Search

Ralph J Gitomer

Examiner (ID: 23, Phone: (571)272-0916 , Office: P/1657 )

Most Active Art Unit
1657
Art Unit(s)
1651, 1627, 1655, 1623, 1622, 1657, 1815, 1211, 1803, 2899
Total Applications
3335
Issued Applications
2101
Pending Applications
286
Abandoned Applications
947
Created with Highcharts 8.2.2Number of ApplicationsStatus of ApplicationsIssuedAbandoned1990199219941996199820002002200420062008201020122014201620180255075100

Applications

Application numberTitle of the applicationFiling DateStatus
96/000262 VIRAL CONJUNCTIVITIS TREATMENT USING RANPIRNASE AND/OR AMPHINASE Jun 27, 2018 Pending
96/000248 METHOD OF FEEDING LIVESTOCK TO IMPROVE CARCASS CHARACTERISTICS Dec 28, 2017 Pending
90/014054 SYSTEMS AND METHODS FOR COUNTING CELLS AND BIOMOLECULES Dec 14, 2017 Issued
90/014027 METHOD FOR THE TREATMENT OF SYMPTOMS RELATED TO NORMAL HORMONAL VARIATIONS IN WOMEN Oct 9, 2017 Issued
15/705553 Local Intraosseous Administration of Bone Forming Agents and Anti-Resorptive Agents, and Devices Therefor Sep 14, 2017 Abandoned
90/013963 Targeting Rare Human PCSK9 Variants for Cholesterol Treatment Jun 13, 2017 Issued
Array ( [id] => 14115655 [patent_doc_number] => RE047333 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-04-02 [patent_title] => Pharmaceutical formulations containing dopamine receptor ligands [patent_app_type] => reissue [patent_app_number] => 15/598784 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12101 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598784 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/598784
Pharmaceutical formulations containing dopamine receptor ligands May 17, 2017 Issued
Array ( [id] => 14167955 [patent_doc_number] => RE047350 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-04-16 [patent_title] => Pharmaceutical formulations containing dopamine receptor ligands [patent_app_type] => reissue [patent_app_number] => 15/598971 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12119 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598971 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/598971
Pharmaceutical formulations containing dopamine receptor ligands May 17, 2017 Issued
15/461054 REGENERATIVE AUTOLOGOUS BONE MARROW CELL THERAPIES AND METHODS FOR THEIR USE IN THE TREATMENT OF JOINT PAIN Mar 15, 2017 Abandoned
90/013885 T CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS Dec 26, 2016 Pending
Array ( [id] => 13247789 [patent_doc_number] => RE047141 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-11-27 [patent_title] => Methods of treating fibrosis, cancer and vascular injuries [patent_app_type] => reissue [patent_app_number] => 15/382065 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 33 [patent_no_of_words] => 24064 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382065 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/382065
Methods of treating fibrosis, cancer and vascular injuries Dec 15, 2016 Issued
Array ( [id] => 13219413 [patent_doc_number] => RE047122 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-11-13 [patent_title] => 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors [patent_app_type] => reissue [patent_app_number] => 15/382135 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26268 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382135 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/382135
2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors Dec 15, 2016 Issued
Array ( [id] => 11857304 [patent_doc_number] => RE046518 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2017-08-22 [patent_title] => 'Compositions relating to a mutant Clostridium difficile toxin and methods thereof' [patent_app_type] => reissue [patent_app_number] => 15/366702 [patent_app_country] => US [patent_app_date] => 2016-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 56 [patent_no_of_words] => 64865 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366702 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/366702
Compositions relating to a mutant Clostridium difficile toxin and methods thereof Nov 30, 2016 Issued
Array ( [id] => 13115455 [patent_doc_number] => RE047045 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-09-18 [patent_title] => Compositions and methods for treating macular degeneration [patent_app_type] => reissue [patent_app_number] => 15/343016 [patent_app_country] => US [patent_app_date] => 2016-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10617 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343016 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/343016
Compositions and methods for treating macular degeneration Nov 2, 2016 Issued
90/013846 MONITORING AMPLIFICATION OF DNA DURING PCR Oct 26, 2016 Issued
Array ( [id] => 11457128 [patent_doc_number] => 20170051033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => 'Variants of C-Type Natriuretic Peptide' [patent_app_type] => utility [patent_app_number] => 15/332793 [patent_app_country] => US [patent_app_date] => 2016-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 74178 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332793 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/332793
Variants of C-Type Natriuretic Peptide Oct 23, 2016 Abandoned
Array ( [id] => 14848327 [patent_doc_number] => RE047607 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-09-17 [patent_title] => Luciferase signal enhancing compositions [patent_app_type] => reissue [patent_app_number] => 15/292259 [patent_app_country] => US [patent_app_date] => 2016-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 46 [patent_no_of_words] => 16812 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15292259 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/292259
Luciferase signal enhancing compositions Oct 12, 2016 Issued
Array ( [id] => 13206035 [patent_doc_number] => RE047115 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-11-06 [patent_title] => Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis [patent_app_type] => reissue [patent_app_number] => 15/230189 [patent_app_country] => US [patent_app_date] => 2016-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9402 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15230189 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/230189
Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis Aug 4, 2016 Issued
Array ( [id] => 14084269 [patent_doc_number] => RE047316 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2019-03-26 [patent_title] => Oral formulations of ospemifene [patent_app_type] => reissue [patent_app_number] => 15/191316 [patent_app_country] => US [patent_app_date] => 2016-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2033 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15191316 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/191316
Oral formulations of ospemifene Jun 22, 2016 Issued
Array ( [id] => 13075913 [patent_doc_number] => RE047009 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2018-08-28 [patent_title] => HDAC inhibitors and therapeutic methods using the same [patent_app_type] => reissue [patent_app_number] => 15/182061 [patent_app_country] => US [patent_app_date] => 2016-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30216 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15182061 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/182061
HDAC inhibitors and therapeutic methods using the same Jun 13, 2016 Issued
Menu
This website is using cookies.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn more
x